Pharmaceutical Press Releases

Ceva Santé Animale (Ceva) and ProBioGen announced the signature of a multi-product license agreement for the use of ProBioGen’s AGE1.CR® avian cell line in the industrial production of viral animal vaccines.

Using the high-resolution structural information, UCB scientists were able to design a novel class of molecules which inhibit MEK and which have the potential to combat cancer.

As European austerity measures lead to cuts in healthcare spending, profits at pharmaceutical companies have been declining or showing little growth for the past year, a trend that some analysts say could continue until at least 2014, as reported in The New York Times.